7 drug(s) with this reaction
8,742 total reports
Hypoaesthesia has been reported as an adverse reaction across 7 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 8,742 adverse event reports mention hypoaesthesia in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with hypoaesthesia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have hypoaesthesia listed in their FDA adverse event reports, sorted by report count:
In addition to hypoaesthesia, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
7 drug(s) manufactured by Amgen Inc have hypoaesthesia listed in their FDA adverse event reports: Otezla, APREMILAST, DENOSUMAB, ERENUMAB-AOOE, CINACALCET HYDROCHLORIDE, and others.
There are a combined 8,742 reports of hypoaesthesia across 7 Amgen Inc drug(s) in the FDA adverse event database.